CAF-Driven EMT and ECM Remodeling Programs Promote Mesothelioma Progression

Our plain-English summary of CAF-Driven EMT and ECM Remodeling Programs Promote Mesothelioma Progression, by L. Wu, H. Yun, H.Y. Sharahi, et al (Cancers, 2026).

The study

• Authors: L. Wu, H. Yun, H.Y. Sharahi, F. Zaeimi, M. de Perrot
• Journal: Cancers
• Published: 2026;18(15)
• Read it: PubMed · Publisher · Free full text

Abstract

Background: The aggressive progression of mesothelioma is driven not only by intrinsic tumor cell plasticity but also by dynamic interactions between tumor cells and the surrounding stromal microenvironment; however, the mechanisms by which stromal populations regulate epithelial-mesenchymal transition (EMT), tumor evolution, and therapeutic resistance remain unclear.

Methods: We integrated longitudinal transcriptomic profiling with single-cell RNA sequencing in a murine intraperitoneal mesothelioma model spanning disease progression from week 0 to week 8 to identify stromal-EMT programs associated with tumor progression. In vitro fibroblast-tumor co-culture systems were used to assess how different fibroblast-to-tumor cell ratios influence transcriptional reprogramming and mesenchymal transition.

Results: Single-cell analysis revealed marked stromal heterogeneity, identifying eight distinct cancer-associated fibroblast (CAF) subtypes: myCAF, mCAF, iCAF, TGF-βCAF, vCAF, plCAF, apCAF, and meCAF. These subsets showed specialized transcriptional programs associated with developmental signaling and metabolic adaptation. Functional analyses demonstrated coordinated intercellular communication across six interconnected modules, including mesenchymal transition, fibrotic remodeling, TGF-β/metabolic adaptation, adhesion signaling, WNT activation, and inflammatory crosstalk. Notably, mCAF, TGF-βCAF, and plCAF populations showed transcriptional convergence, suggesting cooperative formation of a desmoplastic, immunoregulatory niche. Co-culture experiments confirmed that fibroblast-derived signaling induces ratio-dependent transcriptional changes, promoting a shift from epithelioid to mesenchymal phenotypes.

Conclusions: These findings highlight stromal regulation of EMT as a key driver of mesothelioma progression, sarcomatoid transition, and therapy resistance, and identify tumor-stroma signaling networks as potential therapeutic targets.

In plain English

This was a laboratory study in mice and cell cultures. It did not study asbestos exposure. The authors injected a mouse mesothelioma cell line (RN5) into the abdominal cavity of mice. They tracked gene activity in fluid washed from the abdomen from week 0 to week 8. Forty mice were used: 5 untreated controls and 35 tumor-bearing mice examined weekly, 5 per time point. The authors also grew the tumor cells together with mouse lung fibroblasts, at several ratios, for 3 days. They found 14 genes shared between a stromal (supporting-tissue) gene set and a gene set for epithelial–mesenchymal transition (EMT), a shift toward a more invasive cell type. They described eight subtypes of cancer-associated fibroblasts. Matrix-producing and TGF-β-activated subtypes were most strongly linked to these gene programs. In the co-cultures, gene activity changed with the ratio of fibroblasts to tumor cells. The authors concluded that fibroblast-driven EMT is a key driver of mesothelioma progression. They also stated that their data show associations, not direct causality.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Animal experiment (mouse intraperitoneal mesothelioma model) with longitudinal gene-expression profiling and single-cell RNA sequencing, plus an in vitro tumor cell–fibroblast co-culture experiment
• Who was studied: 40 female C57BL/6 mice (Toronto, University Health Network): 5 naïve controls and 35 tumor-bearing mice sacrificed at weekly time points, 5 per group. The co-culture experiment used the RN5 mouse mesothelioma cell line and the CCL-206 mouse lung fibroblast cell line.
• Exposure: No asbestos exposure was studied. Mice received an intraperitoneal injection of RN5 mesothelioma cells (2 million cells per mouse). In culture, RN5 tumor cells were grown with CCL-206 fibroblasts at tumor-to-fibroblast ratios of 0:1, 1:1, 1:5 and 5:1 for 3 days.
• Main results:
  • Comparison of stromal cell-associated genes (n = 42) with Hallmark EMT genes (n = 43) identified 14 shared genes in the tumor-bearing mouse model.
  • Among eight cancer-associated fibroblast (CAF) subtypes, matrixCAFs and TGFβ-CAFs showed very strong to strong enrichment across the EMT29 and Common14 gene programs.
  • PleuralCAFs showed highly specific enrichment for the Stromal28 gene program.
  • Partial overlap was seen among the mCAF, TGF-βCAF and pleuralCAF programs.
  • Composite EMT29 and Stromal28 receptor/ligand scores were significantly increased in tumor-bearing RN5 mouse samples compared with naïve controls (p less than 0.0001). The authors called these interactions putative and hypothesis-generating.
  • In the tumor–fibroblast co-cultures, gene activity changed depending on the tumor-to-fibroblast ratio, involving matrix remodeling, inflammatory signaling, stress adaptation and mesenchymal transition.
  • The authors grouped the fibroblast-induced EMT gene changes in mesothelioma cells into six interconnected functional modules.
• The authors' conclusion: The authors concluded that stromal regulation of EMT is a key driver of mesothelioma progression, sarcomatoid transition and therapy resistance. In their discussion, they also stated that their data do not directly demonstrate this.
• Limitations the authors state:
  • The study identifies associations, not direct causality.
  • The data do not directly show that these programs drive invasiveness, therapy resistance, sarcomatoid features or poor outcomes.
  • Therapy resistance, poor prognosis and sarcomatoid transition should be interpreted cautiously.
  • The roles assigned to CAF subtypes are inferred from gene activity and remain associative.
  • The gene modules are computationally defined and need validation in independent datasets.
  • The receptor–ligand interactions are putative and were not mechanistically confirmed.

Topics

Medical terms in this study, explained in our Lexicon: Mesothelioma, Disease Progression, Fibroblast, Desmoplastic Mesothelioma, Epithelioid, Sarcomatoid.

Related studies

• Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network — Q. Li, W. Wang, et al. (2011)
• Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation — S. Takeuchi, K. Fukuda, et al. (2017)
• Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB — C. Belgiovine, E. Digifico, et al. (2025)
• M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma — T. Fukui, R. Sumitomo, et al. (2025)
• Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling — K. Zhang, D. Chen, et al. (2011)
• Airway wall remodeling induced by occupational mineral dusts and air pollutant particles — A. Churg, J.L. Wright (2002)

Browse more research in Cancers, or return to medical research.